Loading...
Immunosuppressive therapy with rituximab in common variable immunodeficiency
Common variable immunodeficiency (CVID) is the most frequent symptomatic primary antibody deficiency in adulthood and is characterized by the marked reduction of IgG and IgA serum levels. Thanks to the successful use of polyvalent immunoglobulin replacement therapy to treat and prevent recurrent inf...
Na minha lista:
| Udgivet i: | Clin Mol Allergy |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6501382/ https://ncbi.nlm.nih.gov/pubmed/31080365 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12948-019-0113-3 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|